Life sciences · 2005
Protective effects of N-acetylserotonin against 6-hydroxydopamine-induced neurotoxicity.
СтатьяПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Aguiar Lissiana Magna, Macedo Danielle Silveira, de Freitas Rivelilson Mendes, de Albuquerque Oliveira Aline, Vasconcelos Slivânia Maria Mendes, de Sousa Francisca Cléa F, de Barros Viana Glauce S
Аннотация
The present work studied in vivo neuroprotective effects of n-acetylserotonin (NAS), the immediate precursor of melatonin, on the dopaminergic system, in rats lesioned with the unilateral intrastriatal injection of the neurotoxin 6-hydroxydopamine (6-OHDA). Two weeks after the lesion, the dopamine receptor agonist, apomorphine, produced rotational asymmetry, and the NAS treatment significantly reduced the motor deficit following the apomorphine challenge. The apomorphine-induced rotational behavior was blocked by 84, 86 and 53% after NAS, at doses of 2, 5 and 10 mg/kg, i.p., respectively. The injection of 6-OHDA significantly decreased DA, DOPAC and HVA levels in the rat striatum. In contrast, the NAS (2, 5 and 10 mg/kg, i.p., daily for 7 days) treatment partially reversed the decreases caused by 6-OHDA, and the neurotransmitter levels were brought to approximately 50% of that observed in the contralateral sides. NAS was more efficient at the smaller doses. NAS (5 mg/kg) produced an up-regulation of D1 (37%) and D2 (37%) receptors associated with a decrease in Kd values.
Предметные рубрики MeSH
AnimalsApomorphineBenzazepinesBinding, CompetitiveBiogenic MonoaminesCell CountDopamineDopamine AgonistsDopamine AntagonistsMaleMicroinjectionsNeostriatumNeuronsNeurotoxicity SyndromesOxidopamineRatsRats, WistarReceptors, Dopamine D1Receptors, Dopamine D2RotationSerotoninStereotyped BehaviorSympatholytics